In 2019, the Dr. Peter Centre is launching a new project designed to evaluate the efficacy of providing intravenous opioid agonist therapy (iOAT) in an integrated holistic and stigma-free environment.
Our integrated approach means that we work collaboratively with our participants to be actively engaged in their health care. This $2.6-million project, funded by Health Canada, will provide real-life examination of what is involved with implementing and operating a program that allows people to engage in their own health care by offering the use of the medical grade and safe painkiller hydromorphone as an injectable opioid substitute.
With the implementation of iOAT at the Dr. Peter Centre comes access to an evidence-based medical therapy. Over the next two years this program will be made available to 25 participants. We’ll be able to monitor their experience, and equally important, learn what works for them and what doesn’t.
Information obtained from this study will be shared with health service organizations, public health, health care professionals and policy makers across Canada.
Our commitment to removing barriers and reducing the burden of access means these participants will also have access to all of our services – quality food to keep them healthy, counselling services, life skills, music, recreation, and art therapy.
- The opioid crisis continues to be one of the most serious public health issues in Canada's recent history
- Between January 2016 and September 2018, more than 10,300 Canadians died from an apparent opioid-related overdose
"We know there is no silver bullet solution to this crisis, and the services and education these organizations offer are crucial. We must continue to work all together to save lives."
~ Health Minister Ginette Petitpas Taylor
Here's an update on the opioid crisis in Vancouver and the harm reduction conversation.